Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: Implications for the surgical pathologist

Modern Pathology

Volumn 15, Issue 3, 2002, Pages 197-204

  Gal, Anthony A ^a   Velasquez, Alvaro ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Antineutrophil cytoplasmic antibodies; Microscopic polyangiitis; Vasculitis; Wegener's granulomatosis

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CELL NUCLEUS; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CYTOPLASM; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LUNG BIOPSY; LUNG DISEASE; MAJOR CLINICAL STUDY; PATHOLOGIST; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; SEROLOGY; TRANSBRONCHIAL BIOPSY; ULCERATIVE COLITIS; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; BIOPSY; CAPILLARIES; CONNECTIVE TISSUE DISEASES; DIAGNOSTIC ERRORS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUNG; LUNG DISEASES; MIDDLE AGED; PATHOLOGY, SURGICAL; RETROSPECTIVE STUDIES; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0036128463     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880516     Document Type: Article

References (88)

1. Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology?
2. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis
3. Antineutrophil cytoplasmic antibodies: A still-growing class of autoantibodies in inflammatory disorders
4. Antineutrophil cytoplasmic antibodies
5. Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features
6. Association between active Wegener's granulomatosis and anticytoplasmic antibodies
7. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis
8. Different immunological specificities and disease associations of c-ANCA and p-ANCA
9. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase
10. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils
11. Evolving concepts about the role of antineutrophil cytoplasm autoantibodies in systemic vasculitides
12. "False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis
13. Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms
14. Test characteristics of immunofluorescence and ELISA tests in 856 consecutive pateints with possible ANCA-associatied conditions
15. Distinction between antinuclear antibody and P-ANCA
16. Nomenclature of systemic vasculitides. Proposal of an international consensus conference
17. Pulmonary lesions in Wegener's granulomatosis: A clinicopathologic study of 22 autopsy cases
18. The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis: A study based on 35 open lung biopsies
19. The eosinophilic variant of Wegener's granulomatosis
20. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients
21. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients
22. Bronchocentric injury in Wegener's granulomatosis: A report of five cases
23. Pulmonary lesions in Wegener's disease. Report of the French anatomo-clinical research group. Study of 40 pulmonary biopsies
24. Wegener's granulomatosis in the 1990s - A pulmonary pathologist's perspective
25. Common and uncommon manifestations of Wegener's granulomatosis
26. The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic autoantibodies specific for antiproteinase 3 and anti-myeloperoxidase
27. Solitary lung lesions in Wegener's granulomatosis. Pathologic findings and clinical significance in 25 cases
28. Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis. A clinicopathologic study of 16 cases
29. Treated Wegener's granulomatosis: Distinctive pathological findings in the lungs of 20 patients and what they tell us about the natural history of the disease
30. Pulmonary pathology in patients with systemic autoimmune diseases
31. Pitfalls with anti-neutrophil cytoplasmic antibodies (ANCA)
32. ANCA in diseases other than systemic vasculitis
33. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease
34. Churg-Strauss syndrome
35. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance
36. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis
37. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations
38. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis
39. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome
40. Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure
41. Antineutrophil cytoplasmic antibodies in primary Sjogren's syndrome: Prevalence and clinical significance
42. Antineutrophil cytoplasmic antibody in patients with primary Sjogren's syndrome
43. Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis
44. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis
45. Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis
46. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease
47. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis
48. Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases
49. Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: Follow-up of 53 patients
50. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients
51. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease
52. Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease - Report of six cases
53. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis
54. Anticardiolipin and antineutrophil antibodies in giant cell arteritis
55. Antineutrophil cytoplasm antibodies in Kawasaki disease
56. Anti-monocyte cytoplasmic antibodies in granulomatous disease
57. Antibodies to neutrophil cytoplasmic antigens: Serologic marker for Sweet's syndrome
58. Autoantibodies in malaria, tuberculosis and hepatitis B in a West African population
59. Anti-neutrophil cytoplasmic autoantibodies in leprosy
60. False-positive antineutrophil cytoplasmic antibody in aspergillosis with oxalosis
61. False-positive antineutrophil cytoplasmic antibodies in a patient with cavitary pulmonary sporotrichosis
62. C-ANCA positivity in a Belgian patient with pulmonary paracoccidioidomycosis
63. Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis
64. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody
65. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies
66. Antineutrophil cytoplasmic antibodies in leptospirosis
67. Influenza A-associated bronchiolitis obliterans organizing pneumonia mimicking Wegener's granulomatosis
68. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection
69. Anti-nuclear, antineutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals
70. Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection
71. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis
72. Anti-neutrophil cytoplasmic antibodies (ANCA) and infection
73. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study
74. Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies
75. Anti-neutrophil cytoplasmic antibodies (ANCA) in myelodysplasia and other haematological disorders
76. An association between ANCA positive renal disease and malignancy
77. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation
78. ANCA in haemodialysis patients
79. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies
80. Anticytokeratins are a potential source of false-positive indirect immunofluorescence assays for C-ANCA
81. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies
82. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)
83. Antineutrophil cytoplasmic antibodies: An update on clinical utility
84. Antineutrophil cytoplasmic antibodies in inflammatory arthritis - Potential for misdiagnosis?
85. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis
86. Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology. Comparative evaluation of commercial indirect fluorescent antibody kits and enzyme immunoassay kits
87. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis
88. ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis